HEADER HYDROLASE/HYDROLASE INHIBITOR 13-JUL-11 3SW2
TITLE X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH 6-CHLORO-N-((3S)-
TITLE 2 2-OXO-1-(2-OXO-2-((5S)-8-OXO-5,6-DIHYDRO-1H-1,5-METHANOPYRIDO[1,2-
TITLE 3 A][1,5]DIAZOCIN-3(2H,4H,8H)-YL)ETHYL)PIPERIDIN-3-YL)NAPHTHALENE-2-
TITLE 4 SULFONAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR X;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: FACTOR X LIGHT CHAIN (UNP RESIDUES 85-178);
COMPND 5 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR;
COMPND 6 EC: 3.4.21.6;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: COAGULATION FACTOR X;
COMPND 9 CHAIN: B;
COMPND 10 FRAGMENT: ACTIVATED FACTOR XA HEAVY CHAIN (UNP RESIDUES 235-472);
COMPND 11 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR;
COMPND 12 EC: 3.4.21.6
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 TISSUE: BLOOD;
SOURCE 6 MOL_ID: 2;
SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 8 ORGANISM_COMMON: HUMAN;
SOURCE 9 ORGANISM_TAXID: 9606;
SOURCE 10 TISSUE: BLOOD
KEYWDS SERINE PROTEASE, EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, BLOOD
KEYWDS 2 COAGULATION FACTOR, CLEAVAGE ON PAIR OF BASIC RESIDUES, EGF-LIKE
KEYWDS 3 DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, HYDROXYLATION,
KEYWDS 4 ZYMOGEN, HYDROLASE, BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR
KEYWDS 5 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR H.E.KLEI
REVDAT 4 30-OCT-24 3SW2 1 REMARK
REVDAT 3 13-SEP-23 3SW2 1 REMARK LINK
REVDAT 2 07-DEC-11 3SW2 1 JRNL
REVDAT 1 16-NOV-11 3SW2 0
JRNL AUTH Y.SHI,S.P.O'CONNOR,D.SITKOFF,J.ZHANG,M.SHI,S.N.BISAHA,
JRNL AUTH 2 Y.WANG,C.LI,Z.RUAN,R.MICHAEL LAWRENCE,H.E.KLEI,K.KISH,
JRNL AUTH 3 E.C.LIU,S.M.SEILER,L.SCHWEIZER,T.E.STEINBACHER,
JRNL AUTH 4 W.A.SCHUMACHER,J.A.ROBL,J.E.MACOR,K.S.ATWAL,P.D.STEIN
JRNL TITL ARYLSULFONAMIDOPIPERIDONE DERIVATIVES AS A NOVEL CLASS OF
JRNL TITL 2 FACTOR XA INHIBITORS.
JRNL REF BIOORG.MED.CHEM.LETT. V. 21 7516 2011
JRNL REFN ISSN 0960-894X
JRNL PMID 22041058
JRNL DOI 10.1016/J.BMCL.2011.06.098
REMARK 2
REMARK 2 RESOLUTION. 2.42 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_501)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.88
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 3 NUMBER OF REFLECTIONS : 12724
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.199
REMARK 3 R VALUE (WORKING SET) : 0.193
REMARK 3 FREE R VALUE : 0.262
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.850
REMARK 3 FREE R VALUE TEST SET COUNT : 1126
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 32.8786 - 4.8359 0.99 1537 148 0.1941 0.2302
REMARK 3 2 4.8359 - 3.8403 0.99 1480 145 0.1601 0.2173
REMARK 3 3 3.8403 - 3.3554 1.00 1451 140 0.1760 0.2370
REMARK 3 4 3.3554 - 3.0488 1.00 1467 141 0.1825 0.2855
REMARK 3 5 3.0488 - 2.8304 1.00 1440 141 0.2240 0.3335
REMARK 3 6 2.8304 - 2.6636 1.00 1435 140 0.2358 0.3276
REMARK 3 7 2.6636 - 2.5303 1.00 1425 138 0.2689 0.4053
REMARK 3 8 2.5303 - 2.4202 0.97 1363 133 0.2984 0.4004
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : 0.38
REMARK 3 B_SOL : 60.00
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.880
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 16.82900
REMARK 3 B22 (A**2) : -1.76800
REMARK 3 B33 (A**2) : 22.13840
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.009 2264
REMARK 3 ANGLE : 1.085 3068
REMARK 3 CHIRALITY : 0.072 337
REMARK 3 PLANARITY : 0.004 394
REMARK 3 DIHEDRAL : 14.635 794
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3SW2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-11.
REMARK 100 THE DEPOSITION ID IS D_1000066723.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-JUN-09
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12780
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.420
REMARK 200 RESOLUTION RANGE LOW (A) : 77.960
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 200 DATA REDUNDANCY : 5.500
REMARK 200 R MERGE (I) : 0.05900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.42
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8
REMARK 200 DATA REDUNDANCY IN SHELL : 3.80
REMARK 200 R MERGE FOR SHELL (I) : 0.38100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 3ENS
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.39
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15-22% W/V PEG5000 MME, 0.01 M CALCIUM
REMARK 280 ACETATE, 0.35 M SODIUM ACETATE, 0.1 M LITHIUM SULFATE, 0.1 M MES,
REMARK 280 PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.50900
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.97800
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.25750
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.97800
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.50900
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.25750
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2160 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12620 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LYS A 85
REMARK 465 ASP A 86
REMARK 465 GLY A 87
REMARK 465 ASP A 88
REMARK 465 GLN A 89
REMARK 465 CYS A 90
REMARK 465 GLU A 91
REMARK 465 THR A 92
REMARK 465 SER A 93
REMARK 465 PRO A 94
REMARK 465 CYS A 95
REMARK 465 GLN A 96
REMARK 465 ASN A 97
REMARK 465 GLN A 98
REMARK 465 GLY A 99
REMARK 465 LYS A 100
REMARK 465 CYS A 101
REMARK 465 LYS A 102
REMARK 465 ASP A 103
REMARK 465 GLY A 104
REMARK 465 LEU A 105
REMARK 465 GLY A 106
REMARK 465 GLU A 107
REMARK 465 TYR A 108
REMARK 465 THR A 109
REMARK 465 CYS A 110
REMARK 465 THR A 111
REMARK 465 CYS A 112
REMARK 465 LEU A 113
REMARK 465 GLU A 114
REMARK 465 GLY A 115
REMARK 465 PHE A 116
REMARK 465 GLU A 117
REMARK 465 GLY A 118
REMARK 465 LYS A 119
REMARK 465 ASN A 120
REMARK 465 CYS A 121
REMARK 465 GLU A 178
REMARK 465 THR B 244
REMARK 465 ARG B 245
REMARK 465 GLY B 246
REMARK 465 LEU B 247
REMARK 465 PRO B 248
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 122 CG CD OE1 OE2
REMARK 470 LEU A 123 CG CD1 CD2
REMARK 470 THR A 125 OG1 CG2
REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 127 CD CE NZ
REMARK 470 LEU A 131 CD1 CD2
REMARK 470 GLU A 143 CG CD OE1 OE2
REMARK 470 GLN A 144 CG CD OE1 NE2
REMARK 470 ASN A 145 CG OD1 ND2
REMARK 470 ARG A 153 CD NE CZ NH1 NH2
REMARK 470 GLN B 20 CD OE1 NE2
REMARK 470 GLU B 36 CD OE1 OE2
REMARK 470 GLU B 37 CG CD OE1 OE2
REMARK 470 ASN B 38 OD1 ND2
REMARK 470 GLU B 39 CG CD OE1 OE2
REMARK 470 LYS B 62 CG CD CE NZ
REMARK 470 ARG B 63 CG CD NE CZ NH1 NH2
REMARK 470 GLN B 75 CG CD OE1 NE2
REMARK 470 GLU B 77 CG CD OE1 OE2
REMARK 470 LYS B 90 CD CE NZ
REMARK 470 ARG B 93 CD NE CZ NH1 NH2
REMARK 470 LYS B 96 CD CE NZ
REMARK 470 GLU B 97 CD OE1 OE2
REMARK 470 ILE B 112 CD1
REMARK 470 ARG B 115 NE CZ NH1 NH2
REMARK 470 LYS B 134 CD CE NZ
REMARK 470 LYS B 148 CG CD CE NZ
REMARK 470 ARG B 150 CG CD NE CZ NH1 NH2
REMARK 470 ASN B 166 CG OD1 ND2
REMARK 470 LYS B 169 CE NZ
REMARK 470 ILE B 175 CD1
REMARK 470 GLN B 187 CG CD OE1 NE2
REMARK 470 ARG B 202 CZ NH1 NH2
REMARK 470 LYS B 223 CG CD CE NZ
REMARK 470 LYS B 236 CG CD CE NZ
REMARK 470 ARG B 240 CG CD NE CZ NH1 NH2
REMARK 470 LYS B 243 CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 128 -134.99 50.17
REMARK 500 ASP A 132 61.65 32.54
REMARK 500 ASN A 133 25.72 45.61
REMARK 500 GLN A 138 -109.32 -126.94
REMARK 500 LYS A 162 -55.22 -123.76
REMARK 500 ASN B 117 -0.60 72.67
REMARK 500 LYS B 148 74.24 -107.37
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA B 2 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP B 70 OD1
REMARK 620 2 ASN B 72 O 95.1
REMARK 620 3 GLN B 75 O 136.2 75.7
REMARK 620 4 GLU B 80 OE1 72.7 154.2 97.1
REMARK 620 N 1 2 3
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA B 249 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 TYR B 185 O
REMARK 620 2 ASP B 185A O 74.1
REMARK 620 3 ARG B 222 O 148.5 75.4
REMARK 620 4 LYS B 224 O 92.0 101.6 86.5
REMARK 620 N 1 2 3
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FI1 B 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 249
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 8
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3ENS RELATED DB: PDB
REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-
REMARK 900 [(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2-
REMARK 900 PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE
REMARK 900 RELATED ID: 3K9X RELATED DB: PDB
REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-N-((2-
REMARK 900 METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)
REMARK 900 ETHYL)AZEPAN-3-YLAMINO)METHYLENE)NICOTINAMIDE
REMARK 900 RELATED ID: 3HPT RELATED DB: PDB
REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-
REMARK 900 (2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)
REMARK 900 ETHYL)AZEPAN-3-YL)GUANIDINE
DBREF 3SW2 A 85 178 UNP P00742 FA10_HUMAN 85 178
DBREF 3SW2 B 16 248 UNP P00742 FA10_HUMAN 235 472
SEQRES 1 A 94 LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN ASN
SEQRES 2 A 94 GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR CYS
SEQRES 3 A 94 THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU LEU
SEQRES 4 A 94 PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS
SEQRES 5 A 94 ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS
SEQRES 6 A 94 SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS
SEQRES 7 A 94 ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN
SEQRES 8 A 94 THR LEU GLU
SEQRES 1 B 238 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO
SEQRES 2 B 238 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE
SEQRES 3 B 238 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR
SEQRES 4 B 238 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL
SEQRES 5 B 238 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY
SEQRES 6 B 238 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN
SEQRES 7 B 238 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL
SEQRES 8 B 238 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL
SEQRES 9 B 238 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER
SEQRES 10 B 238 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE
SEQRES 11 B 238 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU
SEQRES 12 B 238 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS
SEQRES 13 B 238 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE
SEQRES 14 B 238 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN
SEQRES 15 B 238 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP
SEQRES 16 B 238 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY
SEQRES 17 B 238 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL
SEQRES 18 B 238 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR
SEQRES 19 B 238 ARG GLY LEU PRO
HET FI1 B 1 39
HET NA B 249 1
HET CA B 2 1
HET GOL B 8 6
HETNAM FI1 6-CHLORO-N-((3S)-2-OXO-1-(2-OXO-2-((5S)-8-OXO-5,6-
HETNAM 2 FI1 DIHYDRO-1H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-3(2H,
HETNAM 3 FI1 4H,8H)-YL)ETHYL)PIPERIDIN-3-YL)NAPHTHALENE-2-
HETNAM 4 FI1 SULFONAMIDE
HETNAM NA SODIUM ION
HETNAM CA CALCIUM ION
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 3 FI1 C28 H29 CL N4 O5 S
FORMUL 4 NA NA 1+
FORMUL 5 CA CA 2+
FORMUL 6 GOL C3 H8 O3
FORMUL 7 HOH *83(H2 O)
HELIX 1 1 LYS A 127 CYS A 136 5 10
HELIX 2 2 ALA B 55 TYR B 60 1 6
HELIX 3 3 GLU B 124A THR B 131 1 8
HELIX 4 4 ASP B 164 SER B 171 1 8
HELIX 5 5 PHE B 234 MET B 242 1 9
SHEET 1 A 2 PHE A 139 GLU A 143 0
SHEET 2 A 2 SER A 146 SER A 150 -1 O VAL A 148 N HIS A 141
SHEET 1 B 2 TYR A 155 LEU A 157 0
SHEET 2 B 2 CYS A 164 PRO A 166 -1 O ILE A 165 N THR A 156
SHEET 1 C 7 GLN B 20 GLU B 21 0
SHEET 2 C 7 LYS B 156 PRO B 161 -1 O MET B 157 N GLN B 20
SHEET 3 C 7 THR B 135 GLY B 140 -1 N GLY B 136 O VAL B 160
SHEET 4 C 7 PRO B 198 PHE B 203 -1 O VAL B 200 N ILE B 137
SHEET 5 C 7 THR B 206 GLY B 216 -1 O THR B 206 N PHE B 203
SHEET 6 C 7 GLY B 226 LYS B 230 -1 O ILE B 227 N TRP B 215
SHEET 7 C 7 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228
SHEET 1 D 7 GLN B 30 ILE B 34 0
SHEET 2 D 7 GLY B 40 ILE B 46 -1 O CYS B 42 N LEU B 33
SHEET 3 D 7 TYR B 51 THR B 54 -1 O LEU B 53 N THR B 45
SHEET 4 D 7 ALA B 104 LEU B 108 -1 O LEU B 106 N ILE B 52
SHEET 5 D 7 ALA B 81 LYS B 90 -1 N GLU B 86 O ARG B 107
SHEET 6 D 7 LYS B 65 VAL B 68 -1 N VAL B 66 O HIS B 83
SHEET 7 D 7 GLN B 30 ILE B 34 -1 N LEU B 32 O ARG B 67
SSBOND 1 CYS A 129 CYS A 140 1555 1555 2.04
SSBOND 2 CYS A 136 CYS A 149 1555 1555 2.02
SSBOND 3 CYS A 151 CYS A 164 1555 1555 2.08
SSBOND 4 CYS A 172 CYS B 122 1555 1555 2.06
SSBOND 5 CYS B 22 CYS B 27 1555 1555 2.05
SSBOND 6 CYS B 42 CYS B 58 1555 1555 2.06
SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.04
SSBOND 8 CYS B 191 CYS B 220 1555 1555 2.03
LINK CA CA B 2 OD1 ASP B 70 1555 1555 2.46
LINK CA CA B 2 O ASN B 72 1555 1555 2.41
LINK CA CA B 2 O GLN B 75 1555 1555 2.52
LINK CA CA B 2 OE1 GLU B 80 1555 1555 2.53
LINK O TYR B 185 NA NA B 249 1555 1555 1.95
LINK O ASP B 185A NA NA B 249 1555 1555 3.19
LINK O ARG B 222 NA NA B 249 1555 1555 2.90
LINK O LYS B 224 NA NA B 249 1555 1555 2.42
SITE 1 AC1 14 GLU B 97 TYR B 99 PHE B 174 ALA B 190
SITE 2 AC1 14 GLN B 192 SER B 195 VAL B 213 TRP B 215
SITE 3 AC1 14 GLY B 216 GLY B 218 GLY B 226 ILE B 227
SITE 4 AC1 14 TYR B 228 HOH B 259
SITE 1 AC2 4 TYR B 185 ASP B 185A ARG B 222 LYS B 224
SITE 1 AC3 5 ASP B 70 ASN B 72 GLN B 75 GLU B 77
SITE 2 AC3 5 GLU B 80
SITE 1 AC4 3 LEU B 123 PRO B 124 LEU B 235
CRYST1 57.018 72.515 77.956 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017538 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013790 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012828 0.00000